CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CNMD

Price (delayed)

$50.345

Market cap

$1.5B

P/E Ratio

20.8

Dividend/share

N/A

EPS

$2.42

Enterprise value

$2.27B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 58

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties ...

Highlights
The stock's price to earnings (P/E) is 33% less than its 5-year quarterly average of 31.4
CNMD's EPS is up by 31% QoQ and by 17% YoY
CNMD's quick ratio is down by 27% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX SYK

Key stats

What are the main financial stats of CNMD

CNMD stock price

How has the CONMED stock price performed over time
Intraday
-0.84%
1 week
-4.7%
1 month
10.99%
1 year
15.58%
YTD
24%
QTD
8.9%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.37B
Gross profit
$788.34M
Operating income
$135.59M
Net income
$73.43M
Gross margin
57.6%
Net margin
5.4%
The company's net margin rose by 32% QoQ and by 13% YoY
The net income is up by 30% since the previous quarter and by 15% year-on-year
The operating margin has grown by 24% since the previous quarter and by 13% year-on-year
The operating income has increased by 23% since the previous quarter and by 14% year-on-year

Price vs fundamentals

How does CNMD's price correlate with its fundamentals

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
CNMD P/E details
P/E
20.8
P/B
1.42
P/S
1.1
EV/EBIT
16.39
EV/EBITDA
14.66
EV/Sales
1.66
The stock's price to earnings (P/E) is 33% less than its 5-year quarterly average of 31.4
CNMD's EPS is up by 31% QoQ and by 17% YoY
The stock's price to book (P/B) is 51% less than its 5-year quarterly average of 2.9 but 30% more than its last 4 quarters average of 1.1
CNMD's equity is up by 5% YoY
CNMD's P/S is 47% less than its 5-year quarterly average of 2.1 but 23% more than its last 4 quarters average of 0.9

Efficiency

How efficient is CONMED business performance
CNMD's return on assets is up by 33% since the previous quarter and by 14% year-on-year
The ROE has grown by 29% from the previous quarter and by 9% YoY
CNMD's return on invested capital is up by 26% since the previous quarter and by 26% year-on-year
CNMD's ROS is up by 23% QoQ and by 15% YoY

Dividends

What is CNMD's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did CONMED financials performed over time
CNMD's total assets is 85% greater than its total liabilities
The current ratio has contracted by 29% YoY
CNMD's quick ratio is down by 27% YoY
The company's debt is 23% lower than its equity
The company's debt to equity fell by 9% YoY and by 3.8% QoQ
CNMD's equity is up by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.